Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 38,072 | 38,352 | 30,179 | 23,444 | 13,438 |
| Operating Income | -38,072 | -38,352 | -30,179 | -23,444 | -13,438 |
| Interest Expense | 2,792 | 1,033 | 489 | 87 | 87 |
| Other Income | -202 | 609 | 141 | 66 | 231 |
| Pre-tax Income | -41,066 | -38,776 | -30,527 | -23,465 | -13,294 |
| Net Income Continuous | -41,066 | -38,776 | -30,527 | -23,465 | -13,294 |
| Net Income | $-41,066 | $-38,776 | $-30,527 | $-23,465 | $-13,294 |
| EPS Basic Total Ops | -0.74 | -0.65 | -0.52 | -0.41 | -0.39 |
| EPS Basic Continuous Ops | -0.68 | -0.65 | -0.52 | -0.41 | -0.25 |
| EPS Diluted Total Ops | -0.74 | -0.65 | -0.52 | -0.41 | -0.39 |
| EPS Diluted Continuous Ops | -0.68 | -0.65 | -0.52 | -0.41 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.74 | -0.65 | -0.52 | -0.41 | -0.39 |
| EBITDA(a) | $-38,039 | $-38,320 | $-30,138 | $-23,408 | $-13,403 |